Quick power projection or a holdover from the Cold War? Although the B-1 Lancer's nuclear function has changed, it still ...

the same clinically validated microtubule inhibitor payload used in Adcentrx's lead program, ADRX-0706 (Nectin-4 ADC), currently enrolling patients in Phase 1b (NCT06036121). ADRX-0134 offers a ...

Detailed price information for General Dynamics Corp (GD-N) from The Globe and Mail including charting and trades.

Akamis Bio Announces Enrollment of First Patient in Phase 1b FORTRESS Trial of NG-350A in ... platform to deliver novel immunotherapeutic payloads to solid tumors, today announced enrollment ...

Bloomberg today announced the launch of its Real-Time Events Data solution, a suite of notification-driven market event feeds that extract and normalize data from unstructured sources in real time.

These vectors will deliver a genetic payload that can, in turn ... AZD0486 is in a Phase III study for follicular lymphoma and in a Phase II trial for B cell non-Hodgkin lymphoma. The pharma is also ...

Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to deliver novel immunotherapeutic payloads to solid tumors, today ...